Freedom Broker Downgrades Amgen to Hold, Raises Price Target to $470
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsDowngradesPrice TargetHot
Freedom Broker analyst Ilya Zubkov downgrades Amgen (NASDAQ:AMGN) from Buy to Hold and raises the price target from $450 to $470.
Freedom Broker analyst Ilya Zubkov downgrades Amgen (NASDAQ:AMGN) from Buy to Hold and raises the price target from $450 to $470.